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In vitro studies with tumor cells have demonstrated
that oxygen free radicals are involved in the develop-
ment of skin cancers and that variations in the
body's defense mechanisms can modify the course of
the disease. To assess the validity of this hypothesis
in spontaneous tumors, we determined glutathione
S-transferase, superoxide dismutase, reduced and
oxidized glutathione, and thiobarbituric acid reactive
substances in healthy whole skin (n = 95), dermis
(n = 73), and epidermis (n = 69). The values were
compared with those obtained in three types of skin
cancer: basal cell carcinoma (n = 16), squamous cell
carcinoma (n = 6), and melanoma (n = 33). In
healthy skin, glutathione S-transferase, superoxide
dismutase, reduced glutathione, and oxidized glu-
tathione were higher in epidermis than in dermis,
whereas thiobarbituric acid reactive substances were
higher in dermis than in epidermis; whole skin had
intermediate values. These results suggest that there
is an induction of some anti-oxygen free radicals
mechanisms in epidermis as a result of increased
oxygen free radicals production. Glutathione S-trans-
ferase and thiobarbituric acid reactive substances
were higher in all types of tumor than in healthy epi-
dermis but oxidized glutathione was lower. Reduced
glutathione and superoxide dismutase activity were
lower in basal cell carcinoma and squamous cell car-
cinoma samples. Glutathione S-transferase increased,
whereas superoxide dismutase and thiobarbituric
acid reactive substances decreased in melanoma sam-
ples in direct relation to the Clark levels. Higher glu-
tathione S-transferase activity, particularly in the
most invasive forms of melanoma, indicates that this
type of cancer is more malignant. Similarly, a
decrease in superoxide dismutase activity can also
encourage progression of the tumor. These results
are in accord with those from tumor cell cultures
and could suggest new strategies (gene therapy) for
managing skin cancer. Key words: GSH/GSSG,
GST, SOD, TBARS. J Invest Dermatol 119:645±652,
2002
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eactive oxygen species (ROS) and oxygen free
radicals (OFR) can modify several intracellular
processes that, as a result, induce mutagenesis or
impairment of biologic systems that, in turn, can
affect cell survival. The most common OFR are the
singlet oxygen, the hydroxyl radical, and the superoxide anion, all
of which are normally present in skin because of physiologic
metabolic oxidative processes which can increase in some
circumstances, such as ultraviolet (UV) radiation (Meffert et al,
1976). Currently, there is a consensus that ROS and OFR are
directly involved in numerous pathologic processes, including the
initiation and promotion of events that lead to the development of
cancer (Axelrod et al, 1990; Kehrer, 1993; Brar et al 2001).
Fortunately, living organisms have various defense mechanisms
against ROS. These include OFR quenching, scavenging of
damaged molecules, and repairing of molecular injuries, such as
those that occur in DNA strands. Cells have nonenzymatic and
enzymatic anti-oxidant protective mechanisms. Among the former
are reduced glutathione (GSH), ascorbic acid, tocopherols, b-
carotene, ubiquinone, and uric acid. These molecules can quench
the OFR directly and, thus, prevent cellular damage. The
enzymatic systems include catalase, superoxide dismutase (SOD),
thioredoxin reductase, and the GSH-linked enzymes [GSH
reductase, GSH peroxidase, and glutathione S-transferase (GST)].
GSH, therefore, has an important dual function in the protection
against ROS: either as a direct scavenger of OFR or as a cofactor in
the GSH-dependent enzyme systems. SOD is in the ®rst line of
defense. It converts the superoxide anion into hydrogen peroxide,
which, in turn, can generate the extremely powerful hydroxyl
radical as a result of the Fenton reaction in the presence of Fe2+.
Catalase, GSH, and GSH peroxidase prevent the hydroxyl radical
from being generated by transforming the hydrogen peroxide into
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H2O and O2 (PreÂ, 1991; Shindo et al, 1994). Lipoperoxidation by-
products are an index of ROS production, especially that of
hydroxyl radical production, and these can be reasonably reliably
measured as thiobarbituric acid reactive substances (TBARS)
(Janero, 1990; PreÂ, 1991).
Skin is a protective barrier against several external aggressive
agents, especially UV radiation. It is therefore of considerable value
to evaluate the activities of the above-mentioned defensive systems
and to determine the extent of ROS production under different
conditions. Several studies have reported the presence of GSH/
GST and SOD systems in human skin (Raza et al, 1991; Kobayashi
et al, 1993; Singhal et al, 1993; Giralt et al, 1996); however, most of
these studies were conducted on whole skin or on a very limited
number study samples and, further, the characteristics of these
systems separately in epidermis and dermis have not been fully
investigated. The epidermis and the dermis have different cell
populations, vascularity, and intercellular constituents. Also, the
epidermis is more exposed to external agents than is the dermis.
Hence, it is to be expected that the extent of ROS production and
the protective systems against ROS would be different. Shindo et al
(1994), Applegate and Frenk (1995), and Kobayashi et al (1993)
have reported on some of these differences but, to date, no large
study exists of GST, SOD, GSH/oxidized glutathione (GSSG), and
TBARS in human dermis compared with epidermis.
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)
are the most common forms of skin cancer (Brand and Ackerman,
2000) and malignant melanoma (MM) is of utmost importance
because of its malignancy. They have become more common in
recent decades and the prevalence continues to increase (Austoker,
1994; Applegate and Frenk, 1995) probably as a result of our
increasing exposure to UV rays. There is a considerable body of
evidence that suggests that OFR-related systems contribute to the
development of skin cancer and chemoresistance. Consequently, it
has been suggested that some of these systems ought to be modi®ed
in order to improve response to cancer chemotherapy (see
Discussion). As most of these studies have been conducted on
animal and cell culture models, investigation involving spontaneous
human skin tumors would provide new insight into the relationship
between ROS and skin cancer on a molecular level and new
therapeutic possibilities are opened up.
Hence, the main aim of this study was 2-fold: (i) to evaluate
the activities of GST and SOD and the concentrations of GSH
and TBARS in epidermis separate from dermis, and (ii) to
measure these parameters in tissue samples of BCC, SCC, and
MM, and to compare the results with those from healthy
epidermis.
MATERIALS AND METHODS
Preparation and general treatment of samples Normal skin was
obtained from different regions of the body (abdomen, thorax, back,
face, neck, ear, extremities, and groin) from 51 men (mean age
54.7 6 20.8 y) and 50 women (mean age 52.4 6 19.6 y) who were
undergoing surgery. The samples were saved in physiologic saline,
delivered to the laboratory and processed on the same day. Their
phototypes were mainly types III and IV, according to the Fitzpatrick
classi®cation and ®ve cases were phototype II. Skin cancer samples
included 21 BCC (13 nodular ulcerative, four super®cial, two in®ltrated
and two sclerous), seven SCC (three moderately well differentiated and
four well differentiated, of which two were with actinic keratosis), and
34 melanomas (18 super®cial spreading melanoma, 10 lentigo maligna
melanoma, three acral lentigenous melanoma, and three nodular
melanoma). The samples were obtained from 36 male patients
(69.7 6 12.08 y) and 26 female patients (66.5 6 16.9 y) and were taken
mainly from the face, neck, ear, and nose. Their phototypes were types
III and IV. Tumors were surgically excised as spindle-shaped pieces and
sent, in sterile saline, to the pathology laboratory of each participating
hospital where they were sectioned into parallel sagittal slices (about
2 mm thick) perpendicular to the longitudinal axis and submitted to the
standard histopathology staining procedures for diagnosis. From those
samples that were excess to requirements for diagnosis, portions of the
fresh tumor material were removed from the central part of the slices, so
as to avoid the surrounding nontumor material, and submitted to this
study's analyses. All tumor samples were manipulated under cold saline
and processed immediately, or stored at ± 80°C and processed within
1 wk.
The protocol was approved by the Ethics Committee of our
University Hospital de Sant Joan de Reus (Universitat Rovira i Virgili)
with anonymity of patient's data being guaranteed. Written informed
consent was obtained from the patients prior to their tissue samples being
included in this study's analyses.
In normal skin samples, the adipose tissue was carefully dissected out
and the skin was cut into 0.5 3 0.5 cm pieces, which were immersed
overnight in 0.25% trypsin in saline solution at 4°C. After a rinse in
saline, the epidermis was separated from the dermis by gentle tugging
with small tweezers. Five additional healthy skin samples were used to
study the effect of trypsinization; each sample being divided in two parts
with one being submitted to the trypsin procedure, whereas the other
was frozen and the epidermis obtained by scraping with a scalpel. Tumor
samples were ®nely minced with scissors. Except for the chromatofocus-
ing analysis, whole skin, dermis, and tumor samples were homogenized
in 200 mM, pH 6.25 sodium phosphate buffer (1 : 20 or 1 : 50; w/v) in
a Polytron blender (Kinematica, Lucerne, Switzerland) cooled with
crushed ice (speed 6, three strokes of 30 s each, at 30 s intervals).
Epidermis was homogenized in a glass-Te¯on Potter-Elvehjem homo-
genizer. Homogenates were centrifuged at 105,000 3 g in an ultracen-
trifuge (Kontron, Milano, Italy) for 1 h to obtain the crude soluble
supernatant on which the following measurements were performed.
Soluble proteins Soluble proteins were determined by the method of
Lowry et al (1951) using bovine serum albumin as standard (Merck,
Darmstadt, Germany).
GST activity Vmax and Km were calculated using spectrophotometric
kinetic analysis with 1-chloro-2,4-dinitrobenzene as substrate at
concentrations between 0.125 and 1.66 mM and GSH at a constant
concentration of 2 mM (Habig et al, 1974). Spontaneous (background)
activity (without enzyme) was subtracted for each substrate
concentration.
GSH/GSSG GSH and GSSG were determined as described by Hissin
and Hilf (1976) in a LS50 Perkin Elmer, Bacon®eld, UK ¯uorimeter at
350 nm and 420 nm (excitation and emission wavelengths, respectively).
SOD Total SOD activity was measured by the Misra and Fridovich
(1972) method, which is based on the auto-oxidation of epinephrine at
pH 10.2 and monitors the changes in absorption at 480 nm. One unit of
SOD was de®ned as the equivalent amount of tissue or protein that
caused a 50% inhibition of the epinephrine auto-oxidation rate.
TBARS TBARS were determined with a modi®cation of the Buege
and Aust (1978) method, in an LS50 Perkin Elmer ¯uorimeter at
515 nm and 548 nm (excitation and emission wavelengths, respectively)
according to Richard et al (1992). Bis-diethyl-acetal malondialdehyde
was used as a standard.
Chromatofocusing Samples were homogenized (1 : 10 or 1 : 20; w/v) as
described above, but in a 20 mM Tris±HCl buffer (pH 7.2) containing
sucrose (250 mM), GSH (1 mM), and Na2 ethylenediamine tetraacetic
acid (0.1 mM). Crude soluble extract was placed in a glass column
(20 3 1 cm; Pharmacia LKB Biotechnology, Uppsala, Sweden) ®lled
with Polybuffer Exchanger 94 matrix, pre-equilibrated with imidazole
(25 mM, pH 7.3) and eluted with Polybuffer 74. The whole procedure
was carried out at 4°C. Fractions were recovered in an automated
fraction collector and the GST activity was determined in a COBAS-
MIRA centrifugal auto-analyzer (Roche, Basel, Switzerland) using 1-
chloro-2,4-dinitrobenzene and GSH both at 1 mM concentration in the
same buffer that was used for homogenization to correct for
background/blank activity
Statistical analysis Statistical analyses were performed with the SPSS
10.0 program. The Kolmogorov±Smirnov goodness-of-®t test was used
to determine the normality of the distributions. Differences between
means were evaluated by the Student±Fisher t test for paired and
nonpaired samples (normal distributions), based on the results of the
variance analysis. For nonparametric (non-normal distributions) data, the
Wilcoxon (paired samples) and the Mann±Whitney U test (nonpaired
samples) were applied. Correlations between variables were analyzed by
the Pearson correlation coef®cient (r). In those melanoma samples in
which there was suf®cient tissue to conduct all the laboratory
measurements, additional statistical analyses were performed to compare
differences in the analytes with respect to Clark levels of tumor. These
included ANOVA with the post hoc ScheffeÂ test together with the
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multinomial logistic regression analysis. Results were considered
statistically signi®cant when p < 0.05.
RESULTS
After some preliminary validation studies, we were only able to
study all the OFR-related parameters in those samples for which
there was enough tissue remaining. It was not possible therefore to
determine all of the parameters in all of the samples. These
discrepancies in overall numbers of samples assessed are highlighted
in the results tables, where applicable.
In healthy samples, signi®cant differences were observed
between dermis and epidermis. GST values (Vmax and Km), SOD
activity, GSH, and GSSG were higher in the epidermis than in the
dermis, whereas TBARS were lower.
Table I shows that the maximal difference between the two skin
layers was observed for GST Vmax (seven times higher per gram of
tissue) and the minimal difference was observed for SOD activity
(1.5 times higher per milligram of protein). GST af®nity was only
slightly lower, albeit statistically signi®cant (p = 0.016), in the
epidermis than in the dermis (higher Km value). Conversely,
TBARS were 4.6 times higher in the dermis than in the epidermis
when expressed as per milligram of protein. The results observed in
whole skin samples were in the range between those values
obtained in the separate skin layers (see Table I).
In the epidermis, statistically signi®cant positive correlations
were observed between GST Vmax and several parameters: the Km
value (r = 0.36; p = 0.002), SOD activity (r = 0.68; p < 0.001),
GSH content (r = 0.41; p < 0.001), and GSSG content (r = 0.38;
p = 0.001). SOD activity correlated positively with the GSH
content (r = 0.44; p = 0.027), whereas the amount of GSH was
negatively correlated with TBARS (r = ± 0.48; p = 0.024).
In the dermis, there were statistically signi®cant positive
correlations between GST Vmax and Km values (r = 0.33; p
= 0.004) as well as between SOD activity and TBARS (r = 0.39; p
= 0.048). In turn, TBARS correlated negatively with the GSSG
content (r = ± 0.47; p = 0.015).
OFR-related parameters in skin cancer samples were
signi®cantly different from healthy epidermis and whole
skin but depended on the type of tumor Table I also shows
the results from tumor samples together with those from normal
epidermis and whole skin. GST Vmax was higher in all tumor
samples than in normal epidermis and whole skin. In BCC and
SCC this increase was only signi®cant in comparison with whole
skin samples, especially when expressed as per gram of tissue. GSH
content was roughly similar in all three types of tumors and only
signi®cantly lower in BCC samples than in healthy epidermis when
expressed as per milligram of protein. All tumors showed higher
GSH values than normal whole skin, when expressed as per gram of
tissue. GSSG content was lower in all tumors than in healthy
epidermis but clearly higher than in whole skin when expressed as
per gram of tissue. These differences in¯uenced the value of the
GSH/GSSG ratio, which was signi®cantly higher in BCC than in
normal epidermis and also higher in MM than in normal epidermis
and whole skin. In BCC and SCC samples, SOD activity was lower
than in epidermis, but particularly low in comparison with whole
skin when expressed as per milligram of protein. In MM samples,
SOD was not different from epidermis but higher than in whole
skin when expressed as per gram of tissue.
Finally, TBARS were clearly higher in all tumor samples,
especially in the SCC group, than in healthy epidermis. This was
not the case in comparison with whole skin, especially when
expressed as per milligram of protein.
In melanomas, GST Vmax, SOD activity, and TBARS
content depended on the Clark level of the tumor In the
15 samples in which there was suf®cient tissue to measure all the
proposed analytes, GST activity increased progressively as the Clark
level increased and the mean values ranged between 261 (level II)
Table I. In healthy skin samples, there were numerous differences between dermis and epidermis for all parameters
analyzed. In whole skin, intermediate values were found. Many differences were found between tumor samples and normal
epidermis and between tumor samples and whole skin and the pattern depended on the type of tumor
Parameter Whole skin Dermis Epidermis SCC BCC MM
GST Vmax
nmol per min per mg protein 204.45 6 133.6 60.6 6 41.3 271.2 6 166.6d 341.23 6 192.7e 349.67 6 310.4 372.6 6 146.7c,h
nmol per min per g tissue 1507 6 1164 940 6 684 6881 6 4985d* 9295 6 6202g* 9722 6 14 433 g* 9671 6 5558a,h*
GST Km (mM) 1.32 6 0.5 1.26 6 0.5 1.54 6 0.7
a 1.48 6 0.7 1.68 6 0.9 1.51 6 0.6
n 95 73 69 6 16 33
GSH
mg per mg protein 10.24 6 4.02 6.7 6 2.2 12.0 6 4.0d 11.42 6 9.26 9.3 6 3.6a 12.65 6 4.0 g
mg per g tissue 71.31 6 32.58 103.7 6 37.1 300.6 6 12.0d 249.67 6 156.9e 181.5 6 124.4c,g 311.6 6 146.8 h
GSSG
mg per mg protein 12.85 6 7.73 9.1 6 3.3 20.1 6 7.4d 13.23 6 7.61a 15.17 6 22.1 11.12 6 6.2d
mg per g tissue 89.29 6 55.19 141.9 6 63.3 505.5 6 225.4d 293.8 6 128.3a,e 177 6 121.3d,e 243.4 6 104.6d,h
GSH per GSSG 0.99 6 0.57 0.81 6 0.3 0.67 6 0.3d* 0.91 6 0.5 1.16 6 0.7a* 1.76 6 1.8d,f*
n 95 73 69 6 15 33
SOD
U per mg protein 29.64 6 12.61 11.4 6 4.9 16.7 6 5.7c 11.55 6 8.32e 10.33 6 9.85a,g 20.44 6 7.7e
U per g tissue 214.19 6 86.68 176.4 6 51.7 412.1 6 109.2d 249.3 6 129.2a 264.5 6 213.5 424.9 6 160.6 h
n 26 26 26 3 6 15
TBARS
nmol per mg protein 1.13 6 0.71 0.64 6 0.3 0.14 6 0.13d 0.61 6 0.18d 0.451 6 0.32a,e 0.364 6 0.17d,h
nmol per g tissue 8.07 6 3.74 10.1 6 4.5 3.6 6 2.9d* 13.92 6 2.6d,e 10.09 6 6.3a 7.57 6 3.6c
n 26 26 22 3 8 15
Mean 6 SD are represented separately for whole skin, dermis, epidermis, and tumor samples expressed either as per milligram of protein or as per gram of tissue. n: indi-
cates the number of samples analyzed in each group of analytes. Results from dermis and epidermis were compared using nonpaired tests as the numbers of samples available
for analyses were not always the same. When paired tests were used, the levels of statistical signi®cance for paired samples (not shown) were of the same magnitude or high-
er than those presented here; p-values for the epidermis±dermis comparisons are indicated in the ``epidermis'' column with a, b, c, or d superscripts (< 0.05, < 0.01,
< 0.005, or < 0.001, respectively). Tumor values were compared with those obtained in healthy epidermis using nonpaired tests (p-values are expressed as superscripts a, b,
c, or d with values of < 0.05, < 0.01, < 0.005, or < 0.001, respectively). Tumor values were also compared with those obtained in whole skin using nonpaired tests and the
p-values are expressed by e, f, g, or h superscripts, corresponding to < 0.05, < 0.01, < 0.005, or < 0.001, respectively. The absence of superscript means the differences were
not statistically signi®cant. (*)indicates a statistical signi®cance obtained by the Mann±Whitney U test. All other comparisons are with unpaired Student t test.
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and 474 nmol per min per mg protein (level V); SOD activity
decreased from a mean value of 25 (level II) to 10 U per mg protein
(level V); and TBARS decreased from a mean value of 0.53 (level
II) to 0.14 (level V) nmol per mg protein.
To evaluate these differences further we performed an ANOVA
analysis on the results from these samples (n = 15). We grouped
samples with Clark levels IV (n = 2) and V (n = 1) together to
meet the minimum statistical requirements (n = 3). (It is dif®cult to
obtain samples with high Clark levels as they are, fortunately, quite
rare.) As can be observed in Table II, TBARS content and SOD
activity signi®cantly decreased as the Clark level increased. The
GST activity increased, although it did not reach statistical
signi®cance. The inverse relationship observed between GST
activity and SOD activity and between GST activity and TBARS
content in the three Clark levels made it possible for us to create
two new variables, i.e., GST/SOD and GST/TBARS ratios. The
values obtained with these new variables also showed a clear
relationship with the Clark level, the ratios being lowest at level II
and highest at level IV + V. The ANOVA analysis of these variables
demonstrated signi®cant differences between groups, particularly in
the case of the GST/TBARS ratio (see Table II).
Soluble protein content in the three Clark groups was not
signi®cantly different. Finally, multinomial logistic regression
analysis was carried out using the Clark level as the dependent
variable (levels II, III, and IV + V) and the GST activity, SOD
activity, TBARS content, GST/SOD, and GST/TBARS as
predictor variables. The ± 2 log-likelihood test for these variables
demonstrated that they were all good predictors of the Clark level,
as can be seen in Table III.
Chromatofocusing analysis showed that the two major GST
isoenzymes were the basic and the acidic forms The acidic
GST form was eluted from the column as a clearly identi®ed peak.
In healthy dermis and epidermis, this form made up slightly more
than 50% of total activity. The basic isoenzymes that eluted off the
column had a more heterogeneous pattern and made up about 45%
of total activity in both the dermis and the epidermis. Neutral GST
isoforms, which also appeared in some samples, made up only 3±4%
of total activity. In all tumor samples (®ve BCC, one SCC, and one
MM) the acidic activity increased to about 80%, whereas basic
forms dropped to 20% of the total GST activity. In four BCC
samples, the neutral activity was found to be 2%. Table IV
summarizes these results and Fig 1 shows the chromatofocusing
pro®le of the epidermis and the BCC samples.
DISCUSSION
In healthy samples, the results clearly show that the three protective
systems studied (GST, GSH/GSSG, and SOD) were higher in
epidermis than in dermis. This could be the result of the different
cell patterns of the two skin layers or of an adaptive response, as the
epidermis is more exposed to environmental agents than the
dermis. This implies that the metabolic processes and the produc-
tion of endogenous OFR of the two skin layers are different.
The main GST isoenzymes and the relative activities of the
various peaks obtained by chromatofocusing were similar in the
dermis and the epidermis (Table IV) and the characteristics of the
dermal GST system (i.e., Vmax and Km) are similar to those we
described in the human sebaceous gland (Giralt et al, 1996). Hence,
the Km value of GST may be higher in epidermis than dermis not
because of isoenzyme differences in the two skin layers but because
of a greater production of some OFR in epidermis, which would
tend to lower the af®nity of the enzyme. On the other hand, the
greater SOD activity observed in the epidermis may be a response
Table II. In melanoma samples, OFR-related parameters depended on the Clark level
Clark level II (n = 6) III (n = 6) IV + V (n = 3) p
GST Vmax
nmol per min per mg protein 261.8 6 123.4 377.4 6 147.5 409.0 6 96.3 NS
nmol per min per g tissue 5774 6 3083 8670 6 5742 9620 6 3636 NS
SOD
U per mg protein 24.8 6 5.6 21.7 6 7.4 10.3 6 0.5 0.016
U per g tissue 517.2 6 181.1 423.9 6 83.0 238.1 6 31.5 0.032
TBARS
nmol per mg protein 0.53 6 0.2 0.33 6 0.07 0.18 6 0.06 0.007
nmol per g tissue 10.6 6 4.2 7.0 6 2.7 4.2 6 1.4 0.04
GST/SOD 11.7 6 7.8 20.1 6 13.9 39.7 6 10.2 0.013
GST/TBARS 593.7 6 432.4 1124 6 432.4 2352 6 804.5 0.001
Results (mean 6 SD) are grouped with respect to the Clark level of melanomas (n = 15). The values are expressed as per milligram of protein or as per gram of tissue.
p-values were obtained from the ANOVA test. Post hoc analysis by the ScheffeÂ test indicated that the signi®cance lay only between levels II and IV + V for the values of
SOD, TBARS and GST/SOD, whereas the differences in the GST/TBARS ratios between all the three levels were statistically signi®cant.
Table III. The multinomial logistic regression analysis demonstrated that OFR-related parameters were good predictors of
the Clark level in melanoma samples
Parameters p % correct Incorrect cases
GST + SOD + TBARS
per mg of protein
0.001 93.3 1 level II case, expected for level III
GST + SOD + TBARS
per g of tissue
< 0.001 100 0 cases
GST/SOD + GST/TBARS 0.001 86.7 1 level II case, expected for level III
1 level III case, expected for level II
The statistical signi®cance (p) was calculated from the ±2 log-likelihood ratio test in the best-®t ®nal model for each of the three groups of variables:
GST + SOD + TBARS both as per milligram of protein as well as per gram of tissue, and GST/SOD + GST/TBARS. The Clark level and number of samples are as in
Table II.
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to a higher production of superoxide anion. So, if this radical is
neutralized by the SOD system, more H2O2 will be produced,
which in turn may determine the formation of hydroperoxides.
Consequently, there ought to have been more TBARS in
epidermis than in dermis, but this was not so. This apparent
discrepancy may be explained by the greater activity of the
protective systems found in epidermis determining a more
favorable balance between anti-OFR systems and TBARS content
than in dermis. In a pilot study, Shindo et al (1994) reported
differences in SOD activity in the dermis and epidermis that were
identical to those observed in our study; albeit their absolute values
were different from ours, probably due to methodologic differ-
ences. Additionally, they found that other enzymes (GSH
reductase, GSH peroxidase, and catalase) were higher in the
epidermis than in the dermis. In their study, catalase activity, in
particular, was between four and eight times higher when expressed
as per milligram of protein and as per gram of tissue, respectively.
Overall, this explains, in part, why TBARS are lower in epidermis
than in dermis. The evaluation of the lipoperoxidation by-products
using the original colorimetric TBARS analysis may be open to
criticism due to lack of speci®city of the method, especially when
the purpose is to measure malondialdehyde formation. The use of
¯uorimetry to measure TBARS (Richard et al, 1992) increases
speci®city and sensitivity, although by-products other than
malondialdehyde are also TBARS. The purpose of our study was
to evaluate not only malondialdehyde but also many other by-
products resulting from the reaction with hydroperoxides; thus, the
low speci®city of the TBARS reaction can be considered, under
the present circumstances, as an advantage, especially as it is a
simple and rapid method. In summary, it seems reasonable to accept
that the more developed anti-OFR systems in normal epidermis are
a physiologic consequence of a greater production of OFR than in
dermis. When speci®c defense mechanisms work ef®ciently,
damage to speci®c molecules is prevented (lower TBARS content
in epidermis than in dermis), but any imbalance in the production±
inhibition of OFR will increase the risk of degenerative processes
such as epidermal cancers.
Before discussing the tumor results in detail, two aspects need to
be highlighted. First, it seems more appropriate that they should be
compared with normal epidermal samples because of their
epidermal origin and because both types of samples presented
similar amounts of protein per gram of tissue. So, we shall base the
following section of the discussion above all on the healthy
epidermal samples (though comparisons between tumor samples
and whole skin can be drawn from Table I). Secondly, tumor
samples were not treated with trypsin as had the normal samples.
Hence we needed to verify that this treatment did not alter the
analytical measurements in healthy skin. The values obtained from
frozen whole skin and dermal samples (after the epidermis had been
scraped off) were similar to those obtained after trypsin incubation
(results not shown). On the other hand, in epidermal samples
obtained by scraping, the amount of soluble protein recovered was
considerably lower than when samples were obtained by
trypsinization. So we concluded that the freezing and scraping
procedure destroyed a signi®cant number of epidermal cells and
therefore led to a loss of soluble fraction. As such, the trypsinization
procedure is more appropriate than the freezing±scraping technique
for separating dermis from epidermis and for performing compari-
sons between the skin layers as well as between tumor samples and
healthy epidermis.
In all tumor samples, GST activity was higher than in healthy
epidermis but the difference was only statistically signi®cant in MM
samples, probably due to the small number of BCC and SCC
samples. Chromatofocusing results demonstrated that the greater
GST activity in tumor samples was mainly due to the increase in
the pi isoform. TBARS were 2.6±4.3 times higher than in healthy
epidermis. GSH content and SOD activity were lower than in
normal epidermis only in BCC and SCC samples. The ANOVA
analysis (Table II) and the multinomial logistic regression analysis
(Table III) demonstrated some interesting relationships between
OFR-related parameters and the stage of MM samples: GST
activity increased with the Clark level, whereas the amount of
TBARS and SOD activity was inversely related to the Clark level.
Moreover, the GST/SOD and GST/TBARS ratios also increased
with the Clark level. Finally, the multinomial logistic regression
analysis also con®rmed that all three parameters and their corres-
ponding ratios are very good predictors of the Clark level. To
summarize, tumor samples were characterized by an increase in
GST activity and TBARS content, and by a decrease in SOD
activity.
Previous reports related to these parameters should now be
discussed. GST has been shown to increase in many human tumor
tissues or tumor cell lines (Mannervik et al, 1987; Shea et al, 1988;
Lafuente et al, 1990; Zhang et al, 1994), and in normal skin after
UV irradiation (Iizawa et al, 1994), especially in the pi isoform. In
this respect, the GSH/GST system is considered part of the aptly
termed multidrug resistance system, such as P-glycoprotein and
topoisomerase II. So, tumor cells with high GST activity are
considered to be particularly resistant to anti-neoplastic drugs, as is
the case in melanoma-derived cell lines (Serrone and Hersey,
1999). Also, the overexpression of GST in tumor cells seems to be
linked to the expression of such oncogenes as the mutated N-Ras
oncogene, which has recently been implicated in melanoma
resistance to cisplatin; the roles of two other oncogenes, Bcl-2
and p53, are currently being investigated (Serrone and Hersey,
1999). The GST pi gene has been mapped in the human
chromosome to 11q13 (Moscow et al, 1988), a region in which
the putative proto-oncogenes int2 and hst1 have also been mapped
(Burgess, 1988; Brookes et al, 1989). Consequently, the increase in
GST activity has been considered not only as a tumor marker
(Tsuchida and Sato, 1992) but also as an index of malignancy,
which includes a greater aggressiveness of the tumor and a poorer
prognosis (Gilbert et al, 1993). van Iersel et al, (1999) described the
inhibitory effects of prostaglandin A2 on cell proliferation in
cultures of IGR-39 melanoma cells and concluded that these effects
are probably mediated by an inhibitory effect on the GSTP1-1
isoenzyme.
In contrast to these negative effects of GST, the lack of GST
expression (GSTM and GSTT null genotypes) together with low
enzyme activities could contribute to the development of several
tumors in humans (Heagerty et al, 1996; Lear et al, 1996, 1997;
Yengi et al, 1996; Clapper and Szarka, 1998). As such, GST may be
considered as a Janus-type system, i.e., they are believed to be
protective when speci®c genotypes are present but, conversely, are
predictors of poor prognosis when the enzyme is overexpressed (as
is the case in our MM samples) because of the resistance to
chemotherapeutic regimens.
SOD activity appears to be inversely related to the proliferation
of malignant cells. In cultures of IPC182 and IGR221 melanoma
cells, the end of the exponential growth phase coincided with the
maximal expression of SOD together with a decrease of catalase
and GSH peroxidase activities (Bravard et al, 1999). These authors
also suggest that alterations in anti-oxidant enzyme expression,
especially the decrease in the SOD system, are involved in the
Table IV. Acidic and basic GST isoforms were
predominant in healthy samples. The acidic form was
signi®cantly increased in all tumors
Sample Basic Neutral Acidic
Dermis n = 3 47.1 6 13.4 (3) 3.9 (1) 51.4 6 14.4 (3)
Epidermis n = 5 42.6 6 16.6 (5) 3.1 6 2.1 (2) 54.2 6 36.1 (5)
Tumors n = 7 19.2 6 8.2 (7) 2.2 6 1.0 (4) 77.2 6 8.2 (7)
Mean 6 SD of the percentage of GST activity of the different isoenzymes
eluted from the chromatofocusing column. The numbers of samples that show ac-
tivity for each isoform are in parenthesis.
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Figure 1. Chromatofocusing analysis of GST activity revealed an increase in the acidic isoform in tumor samples. GST activity was
calculated in each eluant fraction (1.2 or 1.7 ml) from the column. The pH was determined every ®ve fractions. The pH values of the peaks are noted
on the chromatofocusing pro®le. (a) Normal epidermis; (b) BCC sample. Triangles: GST activity (mU per ml); circles: pH values.
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proliferation and differentiation of melanoma cells. Picardo et al
(1996) reported that melanoma cells showed an inverse relationship
between SOD and catalase activities, whereas in another study
(Grammatico et al, 1998) it was concluded that alterations in the
scavenger systems were involved in the development of MM.
Bittinger et al (1998) demonstrated that the production of
superoxide anions by melanoma cells was involved in the
mechanism of metastasis. In human melanoma cells, the increase
in SOD downregulates ICAM-1 expression, which is important in
the expansion process of the tumor (Morandini et al, 1999). The
tumor promoter tetradecanoyl-phorbol-acetate inhibits SOD
activity in mouse skin and silimaryn prevents tumor development
and SOD depletion (Zhao et al, 1999). The topical application of
SOD protects against psoralen + UVA-induced in¯ammatory
reactions in murine and human skin (Filipe et al, 1997).
Finally, it has been demonstrated that there is a relationship
between UV exposure, skin cancer, and a TBARS increase
(Meffert et al, 1976; Setlow et al, 1993). Increase of polyunsaturated
fatty acids and an imbalance in the OFR/protective systems in MM
cells leads to a higher production of lipoperoxides (Picardo et al,
1996; Grammatico et al, 1998).
The inverse relationship observed between GST and SOD
activities found in our tumor samples is concordant with previous
reports. BCC and SCC presented less SOD activity than normal
epidermis. The observation that the increase in GST activity in
these tumors was not signi®cantly different from that in healthy
epidermis may be due to the small number of samples studied but it
can also re¯ect a lesser malignancy in comparison with melanoma.
In MM samples, a higher GST activity was found in all cases and an
inverse relationship between GST and SOD activities was observed
as the Clark level increased. This is in agreement with the higher
malignancy of this type of tumor, especially those of the highest
Clark levels.
TBARS were lower in the more invasive forms of MM. This
could be because SOD activity decreases (and less hydroperoxides
are formed) or because there is an increase in catalase and GSH
peroxidase at these stages (see Bravard et al, 1999).
The observation that the parameters studied changed with the
Clark level cannot be attributed to the presence of contaminating
nontumor tissue (e.g., more dermis in the higher Clark level tissue)
as the tumor samples were carefully selected to be free of
surrounding nontumor tissue. Moreover, the soluble protein
content was identical in all melanoma samples, independently of
the Clark level.
It has been suggested that inactivating the GST system would be
a way of increasing the sensitivity of neoplastic cells to chemo-
therapy (Lafuente et al, 1990; O'Dwyer et al, 1991; Khadir et al,
1999). There have been no clinical studies to support this approach
however. It is hoped that gene therapy related to other anti-OFR
systems will be a viable strategy in the treatment of MM (Bravard et
al, 1999). For example, Church et al (1993) showed that
transfecting MnSOD cDNA into human melanoma cells increased
enzyme expression and suppressed their malignant phenotype.
Rieber and Rieber (1999) reported the retroviral transfer of the
anti-sense cyclin D1 gene to differentiation-refractory K1735
melanoma, which, among other changes, leads to the loss of
tumorigenicity in vivo and a greater SOD/peroxidase ratio; both
being associated with replication senescence. Also, transfection of a
human MnSOD cDNA into the promotable mouse epidermal cell
line JB6 clone41 elicits an overexpression of the enzyme and
induces a slower growth rate of the cells (Amstad et al, 1997).
Blocking oxidant activation of transcription factors such as the
nuclear factor-kB (Brar et al 2001), also represents an interesting
strategy.
In conclusion, the present results obtained from clinical samples
coincide with those obtained in cancer cell cultures and animal
models. This is of considerable importance in the better under-
standing of the molecular factors involved in tumor development,
especially those related to OFR and, as such, new strategies,
including gene therapy, may be envisaged for the treatment of skin
cancer.
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